Joseph Doyle

Professor

  • Department of Infectious Diseases, , The Alfred and School of Translational Medicine, Monash University

    Melbourne

  • Level 2, Burnet Institute, 85 Commercial Rd

    Melbourne

    Australia

Accepting PhD Students

PhD projects

1.Developing and implementing ambulatory models of care for people who use drugs
2. Eliminating hepatitis C infection in Australia through pharmacy based treatment scale up
3. Elimination of hepatitis C through rapid testing and treatment

20062024

Research activity per year

Personal profile

Biography

Prof Joseph Doyle is an infectious diseases expert striving to eliminate threats to global health from communicable diseases. He is currently Professor in Infectious Diseases at Monash University, and is jointly appointed at Burnet Institute as Deputy Director of Disease Elimination Program and Head of Infectious Diseases Clinical Research. He continues to work in clinical practice as a senior infectious diseases specialist at Alfred Health.

Prof Doyle is a clinician researcher, dual-trained in infectious diseases and public health medicine. He completed his MPH at the London School of Hygiene and Tropical Medicine, his PhD at Monash School of Population Health, and hold specialist fellowships from Royal Australasian College of Physicians and Australasian Faculty of Public Health Medicine.

Prof Doyle has experience in research leading clinical trials, cohort studies and implementation science projects to prevent and treat communicable diseases. His work focuses on preventing and treating blood borne viruses (such as hepatitis C and HIV) and the health and wellbeing of key populations. He has received over $40 million in research funding including from NHMRC, MRFF, ARC, Paul Ramsay Foundation, and he serves on the steering committees of international and nation trials and cohorts testing new diagnostics and treatments, models of care, and improvements in health systems. 

Prof Doyle has experience in translating important discoveries into national and global clinical guidelines as an advisor to the World Health Organisation and Therapeutic Good Administration. He has been appointed by state and federal governments to statutory bodies to shape infectious diseases guidelines, regulations and treatment access, including the Pharmaceutical Benefits Advisory Committee and Communicable Diseases Network Australia.

He is currently President of Hepatitis Australia, and President of the Australasian Society for Infectious Diseases. 

Research interests

- Infectious and communicable diseases

- Clinical trials and cohort studies

- Implementation science

- Public health research and evaluation

- Infectious and communicable diseases policy 

- Pandemic response, policy and legislation

 

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 10 - Reduced Inequalities
  • SDG 16 - Peace, Justice and Strong Institutions

Education/Academic qualification

Clinical Medicine, PhD, MONASH UNIVERSITY

Award Date: 14 May 2015

Public Health, MPH, London School of Hygiene & Tropical Medicine

Award Date: 1 Sept 2006

Political Science, BA (Hons), University of Melbourne

Award Date: 1 Jul 2005

Medicine, MBBS, University of Melbourne

Award Date: 1 Dec 2002

External positions

Senior Principal Research Fellow, Burnet Institute (Australia)

2023 → …

Head, Infectious Diseases Clinical Research working group, Burnet Institute (Australia)

2023 → …

Deputy Program Director, Disease Elimination, Burnet Institute (Australia)

2017 → …

Co-Head, Viral Hepatitis Elimination Working Group, Burnet Institute (Australia)

20152023

Infectious Diseases Specialist, Alfred Hospital

2011 → …

Research area keywords

  • Viral Hepatitis
  • Public Health
  • Disease Control
  • Disease Prevention
  • Infectious Diseases

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or